Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice

• Published in: Phytomedicine (Stuttgart) Vol. 128; p. 155418
• Main Authors: Ma, Hui, Yue, Grace Gar‑Lee, Lee, Julia Kin-Ming, Gao, Si, Yuen, Ka-Ki, Cheng, Wen, Li, Xiang, Lau, Clara Bik‑San
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.06.2024
• Subjects: Animals; Antineoplastic Agents, Phytogenic - pharmacology; Apigenin - pharmacology; Breast cancer stem cells; Breast Neoplasms - drug therapy; Breast Neoplasms - pathology; Cancer recurrence; Cell Line, Tumor; Cell Movement - drug effects; Cell Proliferation - drug effects; Cell Survival - drug effects; Female; Glucuronates - pharmacology; Humans; Hyaluronan Receptors - metabolism; Metastasis; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells - drug effects; Plant Extracts - pharmacology; Scutellaria - chemistry; Scutellaria barbata; Scutellarin; Xenograft Model Antitumor Assays; PR; BCSCs; SCU; Metastasis; MTT; ATCC; Scutellarin; DMEM; ALDH1; ANOVA; FBS; Cancer recurrence; TNBC; Scutellaria barbata; HPLC; CSCs; DAB; EGF; EGCG; SBW; CP; EMT; ER; bFGF; ECL; RHEB; HER2; Breast cancer stem cells; mTORC1
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2024.155418

Scutellaria barbata D. Don (SB), commonly known as Ban Zhi Lian and firstly documented by Shigong Chen, is a dried whole plant that has been studied for its therapeutic effects on breast cancer, colon cancer, and prostate cancer. Among its various compounds, scutellarin (SCU) has been demonstrated with anti-tumor effects. This study aimed to evaluate the effects of SB water extract (SBW) and scutellarin on breast cancer stem cells (BCSCs), and to investigate their potential therapeutic effects on breast tumors in mice. BCSCs were enriched from human breast cancer cells (MDA-MB-231 and MDA-MB-361) and their characteristics were analyzed. The effects of varying concentrations of SBW and scutellarin on cell viability, proliferation, self-renewal, and migration abilities were studied, along with the underlying mechanisms. The in vivo anti-tumor effects of scutellarin were further evaluated in SCID/NOD mice. Firstly, mice were inoculated with naïve BCSCs and subjected to treatment with scutellarin or vehicle. Secondly, BCSCs were pre-treated with scutellarin or vehicle prior to inoculation into mice. The derived BCSCs expressed CD44, CD133 and ALDH1, but not CD24, indicating that BCSCs have been successfully induced from both MDA-MB-231 and MDA-MB-361 cells. Both SBW and scutellarin reduced the viability, proliferation, sphere and colony formation, and migration of BCSCs. In mice with tumors derived from naïve BCSCs, scutellarin significantly reduced tumor growth, expression of proliferative (Ki67) and stem cell markers (CD44), and lung metastasis. In addition, pre-treatment with scutellarin also slowed tumor growth. Western blot results suggested the involvement of Wnt/β-catenin, NF-κB, and PTEN/Akt/mTOR signaling pathways underlying the inhibitory effects of scutellarin. Our study demonstrated for the first time that both SB water extract and scutellarin could reduce the proliferation and migration of BCSCs in vitro. Scutellarin was shown to possess novel inhibitory activities in BCSCs progression. These findings suggest that Scutellaria barbata water extract, in particular, scutellarin, may have potential to be further developed as an adjuvant therapy for reducing breast cancer recurrence. [Display omitted]